Bessemer Group Inc. Increases Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Bessemer Group Inc. boosted its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 10,053.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 295,050 shares of the company's stock after acquiring an additional 292,144 shares during the period. Bessemer Group Inc. owned 0.60% of Prestige Consumer Healthcare worth $23,041,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in PBH. Kestra Investment Management LLC purchased a new stake in shares of Prestige Consumer Healthcare during the fourth quarter worth $27,000. CIBC Private Wealth Group LLC raised its stake in Prestige Consumer Healthcare by 48.9% during the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after acquiring an additional 152 shares during the last quarter. Headlands Technologies LLC acquired a new position in shares of Prestige Consumer Healthcare during the 4th quarter worth $40,000. GAMMA Investing LLC lifted its stake in Prestige Consumer Healthcare by 18.9% in the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company's stock valued at $108,000 after buying an additional 220 shares in the last quarter. Finally, Huntington National Bank grew its holdings in Prestige Consumer Healthcare by 133.2% in the 4th quarter. Huntington National Bank now owns 1,481 shares of the company's stock valued at $116,000 after buying an additional 846 shares during the period. Hedge funds and other institutional investors own 99.95% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Oppenheimer upped their target price on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a report on Thursday, February 13th. StockNews.com lowered shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Tuesday, April 8th. DA Davidson raised their price objective on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Raymond James upgraded shares of Prestige Consumer Healthcare to a "moderate buy" rating in a research report on Thursday, December 19th. Finally, Royal Bank of Canada raised their target price on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a "sector perform" rating in a report on Friday, March 21st. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Prestige Consumer Healthcare has a consensus rating of "Hold" and a consensus price target of $93.33.

Prestige Consumer Healthcare Trading Down 0.3 %

PBH traded down $0.24 during midday trading on Wednesday, reaching $80.70. 82,080 shares of the company's stock traded hands, compared to its average volume of 284,630. The firm has a fifty day moving average of $84.56 and a two-hundred day moving average of $79.97. The stock has a market capitalization of $4.00 billion, a price-to-earnings ratio of 18.90, a P/E/G ratio of 2.69 and a beta of 0.47. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. Prestige Consumer Healthcare Inc. has a 52 week low of $62.35 and a 52 week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. On average, equities analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, SVP Mary Beth Fritz sold 1,678 shares of the stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $90.00, for a total value of $151,020.00. Following the transaction, the senior vice president now directly owns 17,157 shares of the company's stock, valued at approximately $1,544,130. This represents a 8.91 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.60% of the stock is currently owned by insiders.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.